Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Apple
AAPL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -52.41%-58.39M | -166.94%-19.51M | -108.49%-16.51M | -4.32%-12.15M | 12.20%-10.04M | 34.38%-38.31M | 46.51%-7.31M | 34.55%-7.92M | 30.20%-11.65M | 28.24%-11.44M |
Net income from continuing operations | -87.62%-77.08M | -157.55%-25.88M | -129.64%-20.81M | -76.50%-17.64M | -6.46%-12.75M | 30.03%-41.08M | 26.29%-10.05M | 34.77%-9.06M | 34.20%-10M | 25.15%-11.98M |
Operating gains losses | 864.81%1.04M | 873.72%1.33M | -74.26%-237K | -25.00%24K | -205.33%-79K | 107.84%108K | 222.32%137K | -3.82%-136K | 105.25%32K | 114.29%75K |
Depreciation and amortization | 9.05%1.01M | 18.61%274K | -2.28%257K | 15.49%246K | 6.33%235K | 18.52%928K | 7.94%231K | 28.92%263K | 4.93%213K | 36.42%221K |
Asset impairment expenditure | --0 | ---- | ---- | ---- | ---- | --251K | ---- | ---- | ---- | ---- |
Remuneration paid in stock | 628.95%2.22M | 761.11%465K | 911.54%789K | --629K | 93.60%333K | 297.40%304K | 109.69%54K | 700.00%78K | --0 | -35.58%172K |
Remuneration paid in stock | -22.13%4M | 22.04%1.16M | 3.31%1.34M | -50.48%665K | -46.17%829K | 46.31%5.13M | 45.50%953K | 42.64%1.3M | 47.91%1.34M | 48.65%1.54M |
Other non cashItems | 641.74%3.05M | 3,281.08%1.18M | 519.57%579K | 416.31%737K | 459.35%557K | -88.93%-563K | 55.95%-37K | -38.00%-138K | -210.67%-233K | -297.44%-155K |
Change In working capital | 317.18%7.37M | 70.29%1.96M | 803.14%1.57M | 206.19%3.19M | 163.35%833K | -58.85%-3.39M | 893.79%1.15M | -124.21%-223K | -45.08%-3.01M | -56.55%-1.32M |
-Change in prepaid assets | -708.11%-299K | 111.06%420K | 75.27%163K | 82.35%-27K | -281.25%-671K | -107.81%-37K | 20.61%199K | -83.03%93K | -578.13%-153K | 35.06%-176K |
-Change in payables and accrued expense | 322.83%7.57M | 55.27%1.46M | 532.09%1.39M | 211.84%3.2M | 232.00%1.52M | -33.50%-3.4M | 427.18%939K | -189.17%-321K | -46.75%-2.86M | -72.93%-1.15M |
-Change in other current liabilities | 164.10%103K | 530.77%82K | 260.00%18K | 70.00%17K | -227.27%-14K | 158.21%39K | 156.52%13K | -61.54%5K | 106.54%10K | -88.54%11K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -52.41%-58.39M | -166.90%-19.51M | -108.49%-16.51M | -4.32%-12.15M | 12.20%-10.04M | 34.38%-38.31M | 46.51%-7.31M | 34.55%-7.92M | 30.20%-11.65M | 28.24%-11.44M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -665.42%-2.66M | -3,510.00%-1.08M | -3,500.00%-792K | -2,894.44%-539K | 12.64%-242K | 74.39%-347K | 91.23%-30K | 0.00%-22K | 95.03%-18K | 55.96%-277K |
Capital expenditure reported | -2,603.37%-2.41M | -3,510.00%-1.08M | -3,500.00%-792K | -1,505.56%-289K | -1,173.68%-242K | 92.03%-89K | 71.96%-30K | 0.00%-22K | 94.97%-18K | 96.98%-19K |
Net PPE purchase and sale | ---250K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net investment purchase and sale | ---- | ---- | --0 | ---250K | ---- | ---- | ---- | --0 | --0 | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | -7.95%-258K | --0 | ---- | ---- | ---258K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -665.42%-2.66M | -3,510.00%-1.08M | -3,500.00%-792K | -2,894.44%-539K | 12.64%-242K | 74.39%-347K | 91.23%-30K | 0.00%-22K | 95.03%-18K | 55.96%-277K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -12.52%54.47M | -97.83%857K | 14,197.20%15.3M | 1,998.84%37.91M | -98.91%227K | 50.95%62.27M | 131.30%39.47M | -75.79%107K | -92.38%1.81M | 42,520.41%20.88M |
Net issuance payments of debt | -50.53%14.76M | -100.22%-67K | 38,392.31%14.93M | -53.66%-63K | -10.00%-44K | 19,350.32%29.84M | 73,168.29%29.96M | -8.33%-39K | -7.89%-41K | 0.00%-40K |
Net common stock issuance | 296.25%39.63M | -77.47%2.25M | ---200K | --37.58M | ---- | --10M | --10M | --0 | --0 | ---- |
Proceeds from stock option exercised by employees | -99.88%26K | 0.00%2K | --0 | -98.56%22K | -99.99%2K | -45.42%22.34M | -99.99%2K | --0 | -93.52%1.53M | 50,639.02%20.8M |
Net other financing activities | -36.17%60K | -172.19%-1.33M | 286.30%564K | 16.77%369K | 122.31%269K | -80.38%94K | -324.31%-489K | 17.74%146K | 255.06%316K | 152.08%121K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -12.52%54.47M | -97.83%857K | 14,197.20%15.3M | 1,998.84%37.91M | -98.91%227K | 50.95%62.27M | 131.30%39.47M | -75.79%107K | -92.38%1.81M | 42,520.41%20.88M |
Net cash flow | ||||||||||
Beginning cash position | 163.13%38.87M | 679.99%52.51M | 268.72%54.14M | 18.93%28.77M | 163.13%38.87M | -56.43%14.77M | -41.44%6.73M | -38.91%14.68M | 37.72%24.19M | -56.43%14.77M |
Current changes in cash | -127.87%-6.58M | -161.42%-19.73M | 74.44%-2M | 355.77%25.22M | -209.73%-10.06M | 227.65%23.61M | 950.07%32.13M | 32.93%-7.83M | -248.34%-9.86M | 155.49%9.17M |
Effect of exchange rate changes | -212.30%-548K | -103,800.00%-1.04M | 420.51%375K | -57.64%147K | -112.84%-33K | 176.97%488K | -99.53%1K | 86.40%-117K | 291.71%347K | 33.85%257K |
End cash Position | -18.34%31.74M | -18.34%31.74M | 679.99%52.51M | 268.72%54.14M | 18.93%28.77M | 163.13%38.87M | 163.13%38.87M | -41.44%6.73M | -38.91%14.68M | 37.72%24.19M |
Free cash from | -58.97%-61.05M | -183.98%-20.84M | -117.88%-17.3M | -6.64%-12.44M | 10.24%-10.29M | 35.46%-38.4M | 46.70%-7.34M | 34.49%-7.94M | 31.56%-11.67M | 30.84%-11.46M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.